SCHEMBL6067907

SCHEMBL6067907

O=[N+]([O-])c1ccc(-c2ccc(O)cc2O)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 5/20 0.43
ESR1 P03372 4/20 0.43
CYP2A6 P11509 1/20 0.43
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
HTT P42858 3/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
RUNX1 Q01196 1/20 0.40
CBFB Q13951 1/20 0.40
PGR P06401 2/20 0.39
AR P10275 1/20 0.39
KMT2A Q03164 2/20 0.38
PSMD14 O00487 1/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5704959 0.85 ALOX15 (0.49) ESR2CYP2A6ALDH1A1MAPTGAA
SCHEMBL6136945 0.76 ALOX15 (0.50) CYP2A6ALDH1A1MAPTGAAPGR
SCHEMBL6067980 0.76 CYP2A6 (0.53) ESR2ESR1CYP2A6ALDH1A1MAPT
Hydrochloric Acid SCHEMBL7198371 0.75 ALOX15 (0.49) CYP2A6ALDH1A1MAPTGAAHPGD
SCHEMBL9777499 0.73 CYP2A6 (0.56) CYP2A6ALDH1A1MAPTHTTGAA
SCHEMBL6068076 0.72 CYP2A6 (0.49) CYP2A6ALDH1A1MAPTHTTHPGD
SCHEMBL6068115 0.72 ALDH1A1 (0.47) ESR2ESR1ALDH1A1MAPTHTT
SCHEMBL22834141 0.72 ATM (0.47) ESR2ESR1CYP2A6ALDH1A1MAPT
SCHEMBL29668116 0.72 ATM (0.47) ESR2ESR1CYP2A6ALDH1A1MAPT
SCHEMBL6870732 0.72 TDP1 (0.47) CYP2A6ALDH1A1MAPTHPGDPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN claimed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US claimed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN claimed
EP-1392673-B1 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AG (DE) 2005-06-08 EP claimed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US claimed
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN disclosed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN disclosed
EP-1392673-B1 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AG (DE) 2005-06-08 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 ESR2 1641/4885ESR1 2061/4885CYP2A6 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.